The First International Conference On Heroin Maintenance
New York Academy of Medicine
New York, NY
June 6, 1998

9:30am           Introductions

Alan R. Fleischman M.D., Senior Vice President, The New York Academy of Medicine

Ethan A. Nadelmann, J.D., Ph.D., Director, The Lindesmith Center

9:45am           The Swiss Heroin Prescription Program

Thomas Zeltner, Ph.D., Director of the Swiss Federal Office of Public Health

Ambros Uchtenhagen, M.D., Ph.D., Principal Investigator, Swiss National Project on the Medically Controlled Prescription of Narcotics

11:00am           BREAK

11:15am           Developing Models for Heroin Maintenance Treatment

Australia: Gabriele Bammer, Ph.D., Senior Fellow, National Centre for Epidemiology and Population Health, Australian National University

Netherlands: Professor Wim van den Brink, M.D., Ph.D., Chairman, Dutch Health Council Committee on Medicinal Intervention in Drug Addiction

12:00pm           LUNCH

2:00pm           Commentator Panel: Medical leaders provide their perspectives on opiate treatment and anchor an audience discussion – Hosack Hall

Moderator: Alan R. Fleischman , M.D., Senior Vice President, The New York Academy of Medicine

David C. Lewis, M.D., Director, Center for Alcohol & Addiction Studies, Brown University, Providence, Rhode Island

Martin Schechter, M.D., Ph.D., Faculty of Medicine, University of British Columbia

Alex Wodak, M.D. Director, Alcohol & Drug Service, St. Vincent's Hospital, Sydney, Australia

3:30pm           Concurrent Focus Sessions:

1) Clinical and Treatment Issues – Room 20

Moderator/Presenter: David Marsh, M.D., Clinical Director, Addiction Medicine and Mental Health Services Corporation, Toronto, Canada

Tony Berthel, M.D., Director, Alcohol and Chemical Dependency Programs, Kantonsspital, Winterthur, Switzerland

Robert Haemmig, M.D., KODA-1, Bern, Switzerland

William Shanahan, M.D., Lead Clinician, Drug Dependency Unity, Chelsea and Westminster Hospital, London, Great Britain

2) Research and Evaluation – Room 21

Moderators: Ambros Uchtenhagen, M.D., Ph.D., Principal Investigator, Swiss National Project on the Medically Controlled Prescription of Narcotics

Nicola Metrebian, Research Fellow, Center for Research on Drugs and Health Behavior, Imperial College School of Medicine, London, Great Britain

Martin Schechter, M.D., Ph.D., Faculty of Medicine, University of British Columbia

Thomas Perneger, Ph.D., Medical Epidemiologist, Institute of Social and Preventative Medicine, University of Geneva Medical School, Geneva, Switzerland

Wim van den Brink, M.D., Ph.D., Chairman, Dutch Health Council Committee on Medicinal Intervention in Drug Addiction, The Netherlands

Maria Victoria Zunzunegui, Ph.D., Principal Investigator, School of Public Health, Anduluza, Granada, Spain

3) Legal/Policy Strategies – Room 440

Moderator: Ernest Drucker, Ph.D., Professor of Epidemiology and Social Medicine, Montefiore Medical Center, Bronx, New York

Gabriele Bammer, Ph.D., Senior Fellow, National Centre for Epidemiology and Population Health, Australian National University, Australia

Thomas Zeltner, Ph.D., Director, Swiss Federal Office of Public Health, Switzerland

Michael O'Shaughnessy, Ph.D., Director, British Columbia Center for Excellence in HIV/AIDS, Vancouver, Canada